Epidermal growth factor receptor

Uniprot/Swiss-prot ID EGFR_HUMAN
Protein name Epidermal growth factor receptor
Gene name Name: EGFR
Synonyms: ERBB, ERBB1, HER1
Organism Homo sapiens (Human).
Taxonomic lineage Eukaryota > Metazoa > Chordata > Craniata > Vertebrata > Euteleostomi > Mammalia > Eutheria > Euarchontoglires > Primates > Haplorrhini > Catarrhini > Hominidae > Homo.
Function Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, amphiregulin, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF. Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. May also activate the NF-kappa-B signaling cascade. Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling. Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin.; Isoform 2 may act as an antagonist of EGF action.
PTM S-cysteinyl 3-(oxidosulfanyl)alanine (Cys-Cys)
N-linked (Glc...)
N-linked (GlcNAc...)
Phosphoserine
S-nitrosocysteine
Phosphothreonine
Phosphotyrosine
DePhosphotyrosine
N6-acetyllysine
Topology Preview
Localization Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-pass type I membrane protein. Golgi apparatus membrane; Single-pass type I membrane protein. Nucleus membrane; Single-pass type I membrane protein. Endosome. Endosome membrane. Note=In response to EGF, translocated from the cell membrane to the nucleus via Golgi and ER. Endocytosed upon activation by ligand.; Isoform 2: Secreted.
Gene Ontology(GO) C:basolateral plasma membrane
C:endocytic vesicle
C:endoplasmic reticulum membrane
C:endosome
C:endosome membrane
C:extracellular space
C:Golgi membrane
C:integral to membrane
C:membrane raft
C:nuclear membrane
C:nucleus
C:perinuclear region of cytoplasm
C:Shc-EGFR complex
F:actin filament binding
F:ATP binding
F:double-stranded DNA binding
F:epidermal growth factor-activated receptor activity
F:MAP kinase kinase kinase activity
F:protein heterodimerization activity
F:receptor signaling protein tyrosine kinase activity
P:activation of phospholipase A2 activity by calcium-mediated signaling
P:activation of phospholipase C activity
P:axon guidance
P:cell proliferation
P:cell-cell adhesion
P:cerebral cortex cell migration
P:digestive tract morphogenesis
P:embryonic placenta development
P:fibroblast growth factor receptor signaling pathway
P:hair follicle development
P:innate immune response
P:morphogenesis of an epithelial fold
P:negative regulation of apoptotic process
P:negative regulation of epidermal growth factor receptor signaling pathway
P:negative regulation of protein catabolic process
P:neurotrophin TRK receptor signaling pathway
P:ossification
P:phosphatidylinositol-mediated signaling
P:positive regulation of catenin import into nucleus
P:positive regulation of cell migration
P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle
P:positive regulation of DNA repair
P:positive regulation of DNA replication
P:positive regulation of epithelial cell proliferation
P:positive regulation of fibroblast proliferation
P:positive regulation of MAP kinase activity
P:positive regulation of nitric oxide biosynthetic process
P:positive regulation of protein kinase B signaling cascade
P:protein autophosphorylation
P:protein insertion into membrane
P:regulation of nitric-oxide synthase activity
P:regulation of peptidyl-tyrosine phosphorylation
P:response to UV-A
P:salivary gland morphogenesis
InterPro IPR000494: EGF_rcpt_L
IPR006211: Furin-like_Cys-rich_dom
IPR006212: Furin_repeat
IPR009030: Growth_fac_rcpt_N_dom
IPR011009: Kinase-like_dom
IPR000719: Prot_kinase_cat_dom
IPR017441: Protein_kinase_ATP_BS
IPR001245: Ser-Thr/Tyr_kinase_cat_dom
IPR008266: Tyr_kinase_AS
IPR020635: Tyr_kinase_cat_dom
IPR016245: Tyr_kinase_EGF/ERB/XmrK_rcpt
PDB
EntryMethodÅChainPositions3D
1DNQModel-A25-336
1DNRModel-A337-645
1IVOX-ray3.30A/B25-646
1M14X-ray2.60A695-1022
1M17X-ray2.60A695-1022
1MOXX-ray2.50A/B25-525
1NQLX-ray2.80A25-642
1XKKX-ray2.40A695-1022
1YY9X-ray2.60A25-642
1Z9INMR-A669-721
2EB2X-ray2.50A695-1022
2EB3X-ray2.84A695-1022
2EXPModel-A311-326
2EXQModel-A27-536
2GS2X-ray2.80A696-1022
2GS6X-ray2.60A696-1022
2GS7X-ray2.60A/B696-1022
2ITNX-ray2.47A696-1019
2ITOX-ray3.25A696-1022
2ITPX-ray2.74A696-1022
2ITQX-ray2.68A696-1022
2ITTX-ray2.73A696-1022
2ITUX-ray2.80A696-1022
2ITVX-ray2.47A696-1022
2ITWX-ray2.88A696-1022
2ITXX-ray2.98A696-1022
2ITYX-ray3.42A696-1022
2ITZX-ray2.72A696-1022
2J5EX-ray3.10A696-1022
2J5FX-ray3.00A696-1022
2J6MX-ray3.10A696-1022
2JITX-ray3.10A/B696-1022
2JIUX-ray3.05A/B695-1022
2JIVX-ray3.50A/B695-1022
2KS1NMR-B634-677
2M20NMR-A/B642-697
2RF9X-ray3.50A/B696-1022
2RFDX-ray3.60A/B702-1022
2RFEX-ray2.90A/B/C/D702-1022
2RGPX-ray2.00A702-1016
3B2UX-ray2.58A/B/E/I/M/P/S/V335-538
3B2VX-ray3.30A25-642
3BELX-ray2.30A702-1016
3BUOX-ray2.60A/C1063-1075
3C09X-ray3.20A/D335-538
3G5VX-ray2.00C311-326
3G5YX-ray1.59E311-326
3GOPX-ray2.80A669-1022
3GT8X-ray2.96A/B/C/D696-1022
3IKAX-ray2.90A/B694-1022
3LZBX-ray2.70A/B/C/D/E/F/G/H696-983
3NJPX-ray3.30A/B25-638
3OB2X-ray2.10A1063-1074
3OP0X-ray2.52C/D1066-1076
3P0YX-ray1.80A334-538
3PFVX-ray2.27C/D1066-1076
3POZX-ray1.50A696-1022
3QWQX-ray2.75A1-642
3UG1X-ray2.75A695-1022
3UG2X-ray2.50A695-1022
3VJNX-ray2.34A695-1022
3VJOX-ray2.64A695-1022
3VRPX-ray1.52B1062-1074
3VRRX-ray2.00C1062-1074
3W2OX-ray2.35A698-1022
3W2PX-ray2.05A698-1022
3W2QX-ray2.20A698-1022
3W2RX-ray2.05A698-1022
3W2SX-ray1.90A696-1022
3W32X-ray1.80A696-1022
3W33X-ray1.70A696-1022
4G5JX-ray2.80A696-1022
4G5PX-ray3.17A/B696-1022
4HJOX-ray2.75A696-1022
4I1ZX-ray3.00A695-1022
4I20X-ray3.34A695-1022
4I21X-ray3.37A/B695-1022
4I22X-ray1.71A695-1022
4I23X-ray2.80A695-1022
4I24X-ray1.80A/B695-1022
Sequence
Length: 1210
MRPSGTAGAA LLALLAALCP ASRALEEKKV CQGTSNKLTQ LGTFEDHFLS LQRMFNNCEV VLGNLEITYV QRNYDLSFLK TIQEVAGYVL IALNTVERIP LENLQIIRGN MYYENSYALA VLSNYDANKT GLKELPMRNL QEILHGAVRF SNNPALCNVE SIQWRDIVSS DFLSNMSMDF QNHLGSCQKC DPSCPNGSCW GAGEENCQKL TKIICAQQCS GRCRGKSPSD CCHNQCAAGC TGPRESDCLV CRKFRDEATC KDTCPPLMLY NPTTYQMDVN PEGKYSFGAT CVKKCPRNYV VTDHGSCVRA CGADSYEMEE DGVRKCKKCE GPCRKVCNGI GIGEFKDSLS INATNIKHFK NCTSISGDLH ILPVAFRGDS FTHTPPLDPQ ELDILKTVKE ITGFLLIQAW PENRTDLHAF ENLEIIRGRT KQHGQFSLAV VSLNITSLGL RSLKEISDGD VIISGNKNLC YANTINWKKL FGTSGQKTKI ISNRGENSCK ATGQVCHALC SPEGCWGPEP RDCVSCRNVS RGRECVDKCN LLEGEPREFV ENSECIQCHP ECLPQAMNIT CTGRGPDNCI QCAHYIDGPH CVKTCPAGVM GENNTLVWKY ADAGHVCHLC HPNCTYGCTG PGLEGCPTNG PKIPSIATGM VGALLLLLVV ALGIGLFMRR RHIVRKRTLR RLLQERELVE PLTPSGEAPN QALLRILKET EFKKIKVLGS GAFGTVYKGL WIPEGEKVKI PVAIKELREA TSPKANKEIL DEAYVMASVD NPHVCRLLGI CLTSTVQLIT QLMPFGCLLD YVREHKDNIG SQYLLNWCVQ IAKGMNYLED RRLVHRDLAA RNVLVKTPQH VKITDFGLAK LLGAEEKEYH AEGGKVPIKW MALESILHRI YTHQSDVWSY GVTVWELMTF GSKPYDGIPA SEISSILEKG ERLPQPPICT IDVYMIMVKC WMIDADSRPK FRELIIEFSK MARDPQRYLV IQGDERMHLP SPTDSNFYRA LMDEEDMDDV VDADEYLIPQ QGFFSSPSTS RTPLLSSLSA TSNNSTVACI DRNGLQSCPI KEDSFLQRYS SDPTGALTED SIDDTFLPVP EYINQSVPKR PAGSVQNPVY HNQPLNPAPS RDPHYQDPHS TAVGNPEYLN TVQPTCVNST FDSPAHWAQK GSHQISLDNP DYQQDFFPKE AKPNGIFKGS TAENAEYLRV APQSSEFIGA
Kegg Pathway hsa04010:MAPK signaling pathway - Homo sapiens (human)
hsa04012:ErbB signaling pathway - Homo sapiens (human)
hsa04020:Calcium signaling pathway - Homo sapiens (human)
hsa04060:Cytokine-cytokine receptor interaction - Homo sapiens (human)
hsa04066:HIF-1 signaling pathway - Homo sapiens (human)
hsa04144:Endocytosis - Homo sapiens (human)
hsa04151:PI3K-Akt signaling pathway - Homo sapiens (human)
hsa04320:Dorso-ventral axis formation - Homo sapiens (human)
hsa04510:Focal adhesion - Homo sapiens (human)
hsa04520:Adherens junction - Homo sapiens (human)
hsa04540:Gap junction - Homo sapiens (human)
hsa04810:Regulation of actin cytoskeleton - Homo sapiens (human)
hsa04912:GnRH signaling pathway - Homo sapiens (human)
hsa04915:Estrogen signaling pathway - Homo sapiens (human)
hsa05120:Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human)
hsa05160:Hepatitis C - Homo sapiens (human)
hsa05200:Pathways in cancer - Homo sapiens (human)
hsa05205:Proteoglycans in cancer - Homo sapiens (human)
hsa05212:Pancreatic cancer - Homo sapiens (human)
hsa05213:Endometrial cancer - Homo sapiens (human)
hsa05214:Glioma - Homo sapiens (human)
hsa05215:Prostate cancer - Homo sapiens (human)
hsa05218:Melanoma - Homo sapiens (human)
hsa05219:Bladder cancer - Homo sapiens (human)
hsa05223:Non-small cell lung cancer - Homo sapiens (human)
Disease Reference
KEGG disease H00016: Oral cancer
H00017: Esophageal cancer
H00018: Gastric cancer
H00022: Bladder cancer
H00028: Choriocarcinoma
H00030: Cervical cancer
H00042: Glioma
H00055: Laryngeal cancer
Omim 131550: EPIDERMAL GROWTH FACTOR RECEPTOR; EGFR ;;V-ERB-B AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGEN
211980: LUNG CANCER ALVEOLAR CELL CARCINOMA, INCLUDED;; ADENOCARCINOMA OF LUNG, INCLUDED;; NONSMALL
Drug Reference
Kegg drug D01977: Gefitinib (JAN/USAN/INN); Iressa (TN)
D03350: Canertinib dihydrochloride (USAN)
D03455: Cetuximab (genetical recombination) (JAN); Cetuximab (USAN/INN); Erbitux (TN)
D04023: Erlotinib hydrochloride (JAN/USAN); Tarceva (TN)
D04024: Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate (USAN); Tykerb (TN)
D05350: Panitumumab (genetical recombination) (JAN); Panitumumab (USAN/INN); Vectibix (TN)
D05399: Pelitinib (USAN/INN)
D06407: Vandetanib (JAN/USAN/INN); Caprelsa (TN)
D07907: Erlotinib (INN); Tarceva (TN)
D08108: Lapatinib (INN)
D08950: Neratinib (INN/USAN)
D09689: Varlitinib (USAN/INN)
D09690: Varlitinib tosylate (USAN)
D09724: Afatinib (USAN/INN)
D09733: Afatinib maleate (JAN); Afatinib dimaleate (USAN)
D09883: Dacomitinib (USAN/INN)
D10018: Necitumumab (USAN/INN)
D10031: Zalutumumab (USAN/INN)
D10439: Imgatuzumab (USAN/INN)
DrugBank DB00002: Cetuximab
DB00530: Erlotinib
DB00317: Gefitinib
DB01259: Lapatinib
DB00281: Lidocaine
DB01269: Panitumumab
DB00072: Trastuzumab